Effects of Arbekacin and Vancomycin on Release of Lactate Dehydrogenase and Fragmentation of DNA in LLC-PK1 Kidney Epithelial Cells

T. Watanabe, H. Goi, T. Hara, T. Sugano, Y. Tanaka, Y. Kazuno, Y. Matsuhashi, H. Yamamoto, and T. Yokota. Antibacterial activities of arbekacin, a new aminoglycoside antibiotic, against methicillin-cephem-resistant Staphylococcus aureus. Jpn. J. Antibiotics 40:349–356 (1987). T. Niizato, M. Ohnishi, S. Nishiyama, H. Asaoka, and A. Saito. A study on nephrotoxicity of arbekacin and vancomycin in rats. Jpn. J. Antibiotics 47:664–675 (1994). F. V. Cook and W. E. Farrar. Vancomycin revisited. Ann. Intern. Med. 88:813–818 (1978). H. D. Humes and R. P. O'Connor. Aminoglycoside nephrotoxicity. In R. W. Schrier and C. W. Gottschalk (eds.), Diseases of the kidney, 4th ed., Little, Brown, Boston, MA, 1988, Vol. 2, pp. 1229–1273. R. Hori, K. Yamamoto, H. Saito, M. Kohno, and K. Inui. Effect of aminoglycoside antibiotics on cellular functions of kidney epithelial cell line (LLC-PK1): a model system for aminoglycoside nephrotoxicity. J. Pharmacol. Exp. Ther. 230:742–748 (1984). K. Inui, H. Saito, T. Iwata, and R. Hori. Aminoglycoside-induced alterations in apical membranes of kidney epithelial cell line (LLC-PK1). Am. J. Physiol. 254:C251–C257 (1988). M. Takano, M. Okuda, M. Yasuhara, and R. Hori. Cellular toxicity of aminoglycoside antibiotics in G418-sensitive and-resistant LLC-PK1 cells. Pharm. Res. 11:609–615 (1994). R. N. Hull, W. R. Cherry, and G. W. Weaver. The origin and characteristics of a pig kidney cell strain, LLC-PK1. In Vitro 12:670–677 (1976). T. Nakamura, Y. Hashimoto, T. Kokuryo, and K. Inui. Effects of fosfomycin and imipenem/cilastatin on nephrotoxicity and renal excretion of vancomycin in rats. Pharm. Res. 15:734–738 (1998). T. Nakamura, T. Kokuryo, Y. Hashimoto, and K. Inui. Effects of fosfomycin and imipenem/cilastatin on the nephrotoxicity of vancomycin and cisplatin in rats. J. Pharm. Pharmacol. 51:227–232 (1999). J. D. Blachley and J. B. Hill. Renal and electrolyte disturbances associated with cisplatin. Ann. Intern. Med. 95:628–632 (1981). D. C. Dobyan, J. Levi, C. Jacobs, J. Kosek, and M. W. Weiner. Mechanism of cis-platinum nephrotoxicity: II. Morphologic observations. J. Pharmacol. Exp. Ther. 213:551–556 (1980). W. Lieberthal, V. Triaca, and J. Levine. Mechanisms of death induced by cisplatin in proximal tubular epithelial cells: apoptosis vs. necrosis. Am. J. Physiol. 270:F700–F708 (1996). W. Lieberthal, and J. S. Levine. Mechanisms of apoptosis and its potential role in renal tubular epithelial cell injury. Am. J. Physiol. 271:F477–F488 (1996). A. P. Soler, J. M. Mullin, K. A. Knudsen, and C. W. Marano. Tissue remodeling during tumor necrosis factor-induced apoptosis in LLC-PK1 renal epithelial cells. Am. J. Physiol. 270:F869–F879 (1996).